...scientific advisory board. duVerle was an assistant professor at the University of Tokyo and the National Institute of Advanced Industrial Science and Technology...
...new spinout, OiDE CapiSEA Inc., to develop capillary stem cells. 04/01/2016 Astellas Pharma Inc. (Tokyo:4503) National Institute of Advanced Industrial Science and Technology... ...dopaminergic neural progenitor cells produced by Sumitomo and Hitachi for Parkinson's disease. 07/23/2015 Astellas Pharma National Institute of Advanced Industrial Science and Technology...
...structural information. The partners did not disclose financial details. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan National Institute of Advanced Industrial Science and Technology...
...sickness. The parties could not be reached for comment. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan National Institute of Advanced Industrial Science and Technology...
...screening assay. Patent pending for Kank-based cancer therapy and drug screening; available for licensing through National Institute of Advanced Industrial Science and Technology... ...N. et al. J. Cell. Biol.; published online May 5, 2008; doi:10.1083/jcb.200707022 Contact: Ryoiti Kiyama, National Institute of Advanced Industrial Science and Technology...
...scientific advisory board. duVerle was an assistant professor at the University of Tokyo and the National Institute of Advanced Industrial Science and Technology...
...new spinout, OiDE CapiSEA Inc., to develop capillary stem cells. 04/01/2016 Astellas Pharma Inc. (Tokyo:4503) National Institute of Advanced Industrial Science and Technology... ...dopaminergic neural progenitor cells produced by Sumitomo and Hitachi for Parkinson's disease. 07/23/2015 Astellas Pharma National Institute of Advanced Industrial Science and Technology...
...structural information. The partners did not disclose financial details. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan National Institute of Advanced Industrial Science and Technology...
...sickness. The parties could not be reached for comment. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan National Institute of Advanced Industrial Science and Technology...
...screening assay. Patent pending for Kank-based cancer therapy and drug screening; available for licensing through National Institute of Advanced Industrial Science and Technology... ...N. et al. J. Cell. Biol.; published online May 5, 2008; doi:10.1083/jcb.200707022 Contact: Ryoiti Kiyama, National Institute of Advanced Industrial Science and Technology...